Hospitals in San Diego are taking a scattered approach to patient access for an anti-malaria drug President Donald Trump has touted as a potential treatment for COVID-19, despite warnings from county health officials and some national experts against using it.
High demand for hydroxychloroquine has led to supply shortages and mixed availability at San Diego hospitals. Two healthcare systems told inewsource they’re saving the drug – brand name Plaquenil – to treat COVID-19 patients. UC San Diego Health said it opposes that approach and instead is saving the medication for people with other conditions.
Why this matters
While President Donald Trump has championed hydroxychloroquine as a promising treatment for COVID-19, testing is inconclusive. New demand for the drug during the pandemic has caused confusion and shortages for those who rely on it for other conditions.
The consequences for patients who already take the drug could be significant if they can’t easily get their prescriptions refilled.
“For someone like me with rheumatoid arthritis, it’s the difference between life with manageable pain and life with excruciating pain,” said Laurie Madigan, a 69-year-old San Diegan who is isolating with her husband at their second home in Julian.
Madigan rushed to get a refill the day she read that Trump mentioned the drug, fearing a shortage. It was too late, her pharmacist told her. There was no supply.
Trump began praising hydroxychloroquine during a March 19 news briefing and has repeatedly recommended the drug since then during briefings and spoken highly of it on Twitter.
But the treatment is not backed by reliable scientific evidence. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, and others have cautioned against using the drug for COVID-19. Fauci has said the science is not definitive and there is no evidence hydroxychloroquine has any effect on the virus.
Locally, Dr. Eric McDonald, the county’s medical director of epidemiology and immunization services, emphasized at a news conference last week no evidence shows “any specific drug” is effective to treat COVID-19 patients — a fact the Centers for Disease Control and Prevention backs up.
McDonald said the county does not recommend treating COVID-19 patients with hydroxychloroquine and cautioned against describing “any of these drugs as being specifically useful at this time.”
But at the Trump administration’s urging, the U.S. Food and Drug Administration granted emergency approval on March 28 to use hydroxychloroquine and chloroquine from the nation’s stockpile to treat coronavirus patients. The county later recognized this in a news release.
McDonald also acknowledged in response to a reporter’s question that hydroxychloroquine may have been used locally to treat someone with a serious illness before the person died, but he had no specifics on that case.
Potential consequences: side effects, shortages and worry
Nationally, the sudden use of hydroxychloroquine to treat the coronavirus has divided some in the medical community. For years, it’s been commonly used for malaria, lupus, rheumatoid arthritis and a range of other autoimmune disorders. It’s one of several therapies being studied to treat COVID-19.
Trump has said it’s being distributed widely to states that ask, and 29 million doses have been added to the Strategic National Stockpile.
“I hope it works,” he said, during a news conference last week, adding, “I’m not a doctor, but I’m a person with common sense.”
Doctors in Los Angeles, New York, Louisiana and other places have been using the drug with mixed results.
Side effects of hydroxychloroquine can be serious, said San Diego pharmacist Sally Rafie, an adjunct professor at the UC San Diego School of Pharmacy. For example, she said, the medication can cause heart rhythm issues, making patients feel light-headed or ill.
“So now we have people coming into the hospitals because of side effects, and that’s of course counterproductive,” Rafie said. “Really, the focus with COVID is around prevention. If people can eliminate their exposures or minimize it as much as possible, that’s really going to be their best way to stay safe and stay healthy.”
Rafie, a former president of the San Diego County Pharmacists Association, said local pharmacies have been running into shortages due to high patient demand for the medication during the coronavirus pandemic. She also said she knows of doctors and dentists who stockpiled the drug for themselves and patients not yet sick, adding to the shortage. This has been a problem across the country in recent weeks, with doctors hoarding the drug.
After Madigan’s pharmacist initially said he couldn’t fill her prescription for her rheumatoid arthritis, she got word that he’d found a source for the drug. She got the prescription filled at her SavOn pharmacy in the downtown San Diego Albertsons. Madigan was so overwhelmed that her pharmacist had located the drug that she brought him flowers when she went to pick up the medication.
She currently has enough supply of hydroxychloroquine to get her through June.
After that, Madigan doesn’t know what will happen.
“I’m trying not to let my mind go there,” she said. “These autoimmune diseases are complicated, and when you’re diagnosed with one it takes several months to work out which medication works for you.”
Before she started taking hydroxychloroquine over a decade ago, Madigan said she was in so much pain her husband had to help her get dressed. Driving was also out. Her joints were so swollen she couldn’t turn her neck.
“If worse comes to worse, I will have to try some other options,” she said.
A range of approaches from local medical systems
inewsource asked seven of the region’s healthcare systems about their use of hydroxychloroquine. Three reported treating COVID-19 patients with it, and two said they have not. The others didn’t respond.
UCSD Health has not used the drug for hospitalized patients “to the best of our knowledge,” spokeswoman Jacqueline Carr said in an email. The medication is not being kept on hand for COVID-19 patients, she added.
In a separate statement, UCSD Health said its pharmacies have sequestered their supply of hydroxychloroquine and are dispensing it to existing patients with conditions such as lupus or rheumatoid arthritis.
Without further testing, the health system rejected using the drug to treat COVID-19 patients but is working to assess its potential. “UC San Diego Health does not support the use of medications in ways for which there is not yet scientific evidence to support safety and efficacy,” its statement said.
UCSD Health also said that because it moved quickly to protect its supplies of the medication, patients who rely on the drug will be able to get refills.
The VA Medical Center in La Jolla also has not used hydroxychloroquine to treat COVID-19 patients, spokeswoman Cindy Butler said in an email, though the VA has used the drug for years to treat other conditions.
Scripps Health, Kaiser Permanente and Sharp HealthCare are taking different approaches.
Scripps said in a statement it has developed treatment guidelines and is reserving hydroxychloroquine for its sickest patients suspected or confirmed to have COVID-19.
“The reasoning is, if this drug helps those patients hospitalized for the treatment of COVID in any way, it can be another tool for our provider in their efforts to control this disease,” according to the statement.
Some Scripps patients who need hydroxychloroquine for other conditions may run into problems. New outpatients won’t have access to the drug, the statement said, while current patients can continue to use it for now.
Kaiser is also placing restrictions on the medication. It’s mostly limiting its pharmacy supply to 14-day refills instead of 90-day refills for lupus patients, spokeswoman Jennifer Dailard said in an email.
Some Kaiser patients who use hydroxychloroquine or chloroquine for other conditions received a letter this month saying their doctors would reach out to switch them to other medications.
Similar to Scripps, Kaiser is keeping a supply of hydroxychloroquine available for severely sick patients hospitalized with COVID-19 infections. Use of the medication follows CDC guidelines.
Sharp is using hydroxychloroquine “for hospitalized patients only, and only after consultation with infectious disease specialists,” according to a statement. It’s limiting the medication to COVID-19 patients on a “case-by-case basis,” while preserving the drug for patients with lupus and rheumatoid arthritis.
Non-coronavirus patients who have prescriptions for other conditions also still have access to the drug, Sharp spokesman John Cihomsky said. He added that no refill restrictions have been put in place.
- Editorial Standards Page
- Ethics Policy
- Diversity Statement
- Diversity Staffing Report
- Corrections Policy
- Ownership Structure, Funding
- Founding Date
- Masthead
- Mission Statement with Coverage Priorities
- Fact-checking Standards
- Unnamed Sources Policy
Editorial Standards Page
- Our Mission
- Ethics Policy
- Diversity
- Ownership Structure, Funding and Grants
- Financial Documents
- Fact-checking and Verification Standards
- Unnamed Sources
- Corrections and Clarifications
- Actionable Feedback and Newsroom Contacts
- Masthead
- Byline Policy
- The Trust Project
- Privacy Policy
Our Mission
inewsource is a nonprofit, nonpartisan newsroom dedicated to improving lives in the San Diego region and beyond through impactful, data-based investigative and accountability journalism.
Our Vision
Betrayals of the public trust are revealed and rectified, wrongdoing is deterred, and inequities are illuminated thanks to inewsource’s deep, dogged, fact-based reporting.
Our Values
Truth: Above all else, we value the importance of a free and credible press. Truth is the cornerstone of democracy and the core value for inewsource.
Transparency: We build trust with our readers by adhering to the highest standards and ethics, and to reporting with facts, precision and context.
Collaboration: Our newsroom prioritizes collaboration over competition. We regularly partner with media outlets on reporting projects and to share content.
Community: Our reporting serves the San Diego region, and we strive to build relationships with our audience by getting out into the community to listen and engage.
Ethics Policy
inewsource will conduct its business with the highest standards of decency, fairness and accuracy. These standards shall apply equally to inewsource employees, freelancers and all others engaged in gathering information on behalf of inewsource. All receive a copy of these ethical standards.
In the course of our reporting, we will consistently:
● Identify our organization and ourselves fully and avoid false representations of any kind to any source.
● Obtain consent from all parties before electronically recording any interview or conversation except in extraordinary cases authorized by the Managing Editor and Editor. If a source refuses to be taped, that must be honored; no recordings are to be made without consent.
● Respect the individual’s right to privacy. inewsource will never manipulate or barter private, personal, health, financial or other extraneous information in the course of preparing its reports.
● Any source we describe or write about in any significant manner must be contacted. The employee should document all efforts to contact the source, and if unsuccessful, should summarize these efforts at contact in the body of his/her writing.
In addition, inewsource follows the Code of Ethics of the Society of Professional Journalists. The latest version, revised in 2014, can be found here.
Editorial Independence Policy
We subscribe to standards of editorial independence adopted by the Institute for Nonprofit News (INN) as follows:
Our organization retains full authority over editorial content to protect the best journalistic and business interests of our organization. We will maintain a firewall between news coverage decisions and sources of all revenue. Acceptance of financial support does not constitute implied or actual endorsement of donors or their products, services or opinions.
We accept gifts, grants and sponsorships from individuals and organizations for the general support of our activities, but our news judgments are made independently and not on the basis of donor support. Our organization also may consider donations to support the coverage of particular topics, but our organization maintains editorial control of the coverage. We will cede no right of review or influence of editorial content, nor of unauthorized distribution of editorial content.
Our organization will make public all donors who give a total of $1,000 or more. We will accept anonymous donations for general support only if it is clear that sufficient safeguards have been put into place that the expenditure of that donation is made independently by our organization and in compliance with INN’s Membership Standards.
Diversity
Diverse Voices
Inclusiveness is at the heart of thinking and acting as journalists, and it supports the educational mandate of inewsource. Race, class, generation, gender, sexual orientation, ability, and geography all affect point of view. inewsource believes that reflecting societal differences in reporting leads to better, more nuanced stories and a better-informed community.
inewsource is committed to employment equity and diversity.
Diverse Staffing Report
Below is a breakdown of staffing data at inewsource. We determine the composition of our staff by asking them to self-identify. It is based on a newsroom of 11 and a total staff of 15 as of August 2020. Percentages are based on 15 total survey responses. The numbers include full-time and part-time staff, full-time fellows and full-time and part-time interns.
| All Staff Percentages are based on 15 total survey responses. The numbers include full-time and part-time staff, full-time fellows and full-time and part-time interns. | Newsroom Percentages are based on 15 completed survey responses to this question. | Business Percentages are based on 15 completed survey responses to this question. | |||
| Gender Identity | Gender Identity | Gender Identity | |||
| Women | 80% | Women | 82% | Women | 75% |
| Men | 20% | Men | 18% | Men | 25% |
| Sexual Orientation | Sexual Orientation | Sexual Orientation | |||
| Straight | 87% | Straight | 82% | Straight | 100% |
| LGBTQ-identifying | 7% | LGBTQ-identifying | 7% | ||
| Not specified | 7% | Not specified | 7% | ||
| Speak a language beyond English at home | 33% | Speak a language beyond English at home | 18% | Speak a language beyond English at home | 75% |
| Race/Ethnicity | Race/Ethnicity | Race/Ethnicity | |||
| White | 67% | White | 73% | White | 50% |
| Hispanic or Latinx | 20% | Two or more races | 18% | Hispanic or Latinx | 50% |
| Two or more races | 13% | Hispanic or Latinx | 9% | ||
| Age | Age | Age | |||
| 20-29 | 40% | 20-29 | 45% | 20-29 | 25% |
| 30-39 | 47% | 30-39 | 45% | 30-39 | 50% |
| 60 or older | 13% | 60 or older | 9% | 60 or older | 25% |
* The percentages in the charts have been rounded and may not add up to 100.
Ownership Structure, Funding and Grants
inewsource is a nonprofit organization, whose legal name is Investigative Newsource. It does business as inewsource. The business was incorporated on Aug. 4, 2009 in the state of California. Tax-exempt status as a 501c3 was granted by the IRS on Sept. 15, 2010. inewsource is funded primarily by individual contributions and foundation grants. We are guided by a board of directors.
Editorial independence: Journalists employed by inewsource take no editorial direction from donors whose contributions may support the organization. inewsource will not hesitate to report on its donors when events warrant. Our Editorial Independence Policy details the firewall between journalism and revenue.
To be transparent with the public, inewsource lists its donors on its website. In cases where a donor is the subject of an inewsource story, additional disclosure will be made.
Financial Documents
We do our due diligence to earn your trust in our reporting, as well as in our governance and financial sustainability. All of our financial documents are made available to view so that our supporters can trust we are sound stewards of your philanthropy. Review our IRS Form 990s, audited financial statements and annual reports:
Tax Returns
Financial Statements
Annual Reports
Fact-checking and Verification Standards
Transparency is one of our core values. Today, there is a need to build trust with our audience because new media and ways of communicating spread lies and slanted news faster than “real” news. At the same time, this era of new technologies makes it easier than ever for news organizations to be transparent. People don’t just have to believe us, they can investigate our investigations with our source materials.
Transparency is key to building credibility.
inewsource reporters have primary responsibility for reporting, writing, and fact-checking their stories. But before a story is published, the reporter reviews all facts and sources with an editor or another reporter. Facts must be traced to a primary source.
In addition, we “transparify” certain investigative stories. This process involves publishing a version of the web story with hyperlinks to all the story’s facts. This is proof that all facts have been documented with primary evidence. We do this to build trust with our readers and to be as transparent as we hope the public figures and institutions that we hold accountable will be.
Unnamed Sources
Not all sources are created equal. Some sources cannot speak authoritatively, provide proper analysis or speak specifically to every inquiry placed before them. To maintain the integrity of our reporting, inewsource reporters must select sources who can speak with validity to the topic at hand, and avoid presenting unqualified or underqualified sources as experts.
If an interviewed source has a conflict of interest, or whose qualifications may be tangential or limited, reporters will note that within the context of the story.
It is incumbent upon reporters to fully background their sources to uncover conflicts of interest or slant prior to using them in a story.
Unless discussed prior to an interview, all subjects talking to inewsource journalists are on the record. Specifically, the source is identified by name and title, and their exact or paraphrased words are attributed to them for publication. If journalists speak with sources who are not politicians, public figures or those not commonly interviewed by journalists, staff should explain clearly that information discussed will be on the record and for publication.
There are times, however, when information may be critical for a story but cannot be found or verified by other means. For example, a source may be able to confirm specific information about a series of events they may have witnessed, but have legitimate concerns about using their name or title. The repercussions to the source could be legal, job-related retribution or personal safety. The source and journalist must discuss these potential dangers and terms of use should be agreed upon by both parties.
If inewsource publishes information from an anonymous source, inewsource will explain to readers, in as much detail as possible, why we agreed to anonymity.
Corrections and Clarifications
inewsource strives for accuracy in everything we do, which is why we are committed to fact checking our content. But sometimes we make errors. When that happens, we correct them. We also clarify stories when something we’ve written is confusing or could be misinterpreted.
We endeavor to always be transparent about our commitment to correcting errors and clarifying misperceptions. When staffers see, hear or read about a possible issue with the accuracy of any inewsource content, they are expected to bring it to the attention of an editor and the web producer so it can be evaluated to determine how to proceed.
Including the web producer is key because inewsource is a multimedia news organization and shares its content with multiple partners on multiple platforms. The web producer must alert these partners about corrections and clarifications.
Corrections and clarifications should be included at the bottom of stories and dated.
Actionable Feedback and Newsroom Contacts
Our audiences know the region we cover and have a stake in maintaining and improving the quality of life in San Diego and Imperial counties. We know your knowledge and insights can help shape what we cover and how we cover it. We invite your comments and complaints on news stories, suggestions for issues to cover or sources to consult. We rely on you to tell us when we get it right and when we need to keep pushing.
Your comments, questions and suggestions can be sent to the team as a whole at contact@inewsource.org or you can contact a specific member of our staff.
Masthead
CEO, Editor and Founder: Lorie Hearn, loriehearn@inewsource.org
Lorie Hearn is the chief executive officer, editor and founder of inewsource. She founded inewsource in the summer of 2009, following a successful reporting and editing career in newspapers. She retired from The San Diego Union-Tribune, where she had been a reporter, Metro Editor and finally the senior editor for Metro and Watchdog Journalism. In addition to department oversight, Hearn personally managed a four-person watchdog team, composed of two data specialists and two investigative reporters. Hearn was a Nieman Foundation fellow at Harvard University in 1994-95. She focused on juvenile justice and drug control policy, a natural course to follow her years as a courts and legal affairs reporter at the San Diego Union and then the Union-Tribune.
Hearn became Metro Editor in 1999 and oversaw regional and city news coverage, which included the city of San Diego’s financial debacle and near bankruptcy. Reporters and editors on Metro during her tenure were part of the Pulitzer Prize-winning stories that exposed Congressman Randy “Duke” Cunningham and led to his imprisonment.
Hearn began her journalism career as a reporter for the Bucks County Courier Times, a small daily outside of Philadelphia, shortly after graduating from the University of Delaware. During the decades following, she moved through countless beats at five newspapers on both coasts.
High-profile coverage included the historic state Supreme Court election in 1986, when three sitting justices were ousted from the bench, and the 1992 execution of Robert Alton Harris. That gas chamber execution was the first time the death penalty was carried out in California in 25 years.
In her nine years as Metro Editor at the Union-Tribune, Hearn made watchdog reporting a priority. Her reporters produced award-winning investigations covering large and small local governments. The depth and breadth of their public service work was most evident in coverage of the wildfires of 2003 and then 2007, when more than half a million people were evacuated from their homes.
Managing Editor: Laura Wingard, laurawingard@inewsource.org
Laura Wingard is the managing editor at inewsource. She has been an editor in San Diego since 2002, working at The San Diego Union-Tribune, KPBS and now inewsource. At the Union-Tribune, she served in a variety of roles including as enterprise editor, government editor, public safety and legal affairs editor, and metro editor. She directed the newspaper’s award-winning coverage of the October 2007 wildfires and the 2010 disappearance of Poway teenager Chelsea King. She also oversaw reporting on San Diego’s pension crisis.
For two years, Wingard was news and digital editor at KPBS, overseeing a team of four multimedia reporters and two web producers. She also was the KPBS liaison with inewsource and collaborated with inewsource chief executive officer and editor Lorie Hearn on investigative work by both news organizations.
Wingard also worked at the Las Vegas Review-Journal as the city editor and as an award-winning reporter covering the environment and politics. She also was the assistant managing editor for metro at The Press-Enterprise in Riverside. She earned her bachelor’s degree at California State University, Fullerton, with a double major in communications/journalism and political science.
Assistant Editor and Senior Reporter: Brad Racino, bradracino@inewsource.org
Brad Racino is the assistant editor and a senior reporter at inewsource. He has produced investigations for print, radio and TV on topics including political corruption, transportation, health, maritime, education and nonprofits.
His cross-platform reporting for inewsource has earned more than 50 awards since 2012, including back-to-back national medals from Investigative Reporters and Editors, two national Edward R. Murrow awards, a Meyer “Mike” Berger award from New York City’s Columbia Journalism School, the Sol Price Award for Responsible Journalism, San Diego SPJ’s First Amendment Award, and a national Emmy nomination.
In 2017, Racino was selected by the Institute for Nonprofit News as one of 10 “Emerging Leaders” in U.S. nonprofit journalism.
Racino has worked as a reporter and database analyst for News21; as a photographer, videographer and reporter for the Columbia Missourian; as a project coordinator for the National Freedom of Information Coalition and as a videographer and editor for Verizon Fios1 TV in New York. He received his master’s degree in journalism from the University of Missouri in 2012.
Byline Policy
Most of our articles carry a byline to identify the author. In some cases, inewsource will use a brand byline such as “Staff” or “inewsource” for internal or editorial information about the newsroom. In these instances, inewsource‘s Editor and Managing Editor are responsible for content that uses a brand byline.
The Trust Project
inewsource is proud to be a member of The Trust Project and support efforts to increase transparency in journalism by displaying the 8 Trust Indicators on our stories. We launched the Trust Indicators on Sep. 16, 2020.
Privacy Policy
inewsource has prepared this Privacy Policy to explain how we collect, use, protect, and share information when you use our inewsource.org website (the “Site“) or when you use any of our services (the “Services“).
By using the Site or Services you consent to this Privacy Policy.
Log Data
Like many site operators, we collect information that your browser sends whenever you visit our site (“Log Data”).
This Log Data may include information such as your computer’s Internet Protocol (“IP”) address, browser type, browser version, the pages of our site that you visit, the time and date of your visit, the time spent on those pages and other statistics.
Cookies
Cookies are files with small amount of data, which may include an anonymous unique identifier. Cookies are sent to your browser from a web site and stored on your computer or mobile device.
Like many sites, we use “cookies” to collect information. You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our site.
Certain pages on our site may set other third party cookies. For example, we may embed content, such as videos, from another site that sets a cookie. While we try to minimize these third party cookies, we can’t always control what cookies this third party content sets.
Additionally, we may use third party services — such as those that provide social media conveniences, measure traffic, send newsletters and facilitate donations — that may place cookies on your computer. We don’t have any way of knowing how such services handle the resulting data internally. inewsource makes no claim, nor takes liability for the insecure submission of information via these applications.
Here are the services whose cookies you can find on inewsource.org:
- Sharing buttons for Facebook and Twitter. These use the standard scripts provided by each company.
- Google Analytics, which we use to measure site traffic. Google Analytics gathers certain non-personally identifying information over time, such as your IP address, browser type, internet service provider, referring and exit pages, time stamp, and similar data. We also use Facebook Pixel to measure, optimize and build audiences for advertising campaigns served on Facebook. In particular it enables us to see how our users move between devices when accessing our website and Facebook, to ensure that our Facebook advertising is seen by our users most likely to be interested in such advertising by analyzing which content a user has viewed and interacted with on our website.
- Stripe, which allows us to accept donations through our website.
- Salesforce to manage newsletter subscriber, donor, and other identifiable user data.
- Mailchimp, to manage newsletter distributions. We collect your email address if you choose to subscribe to one of our email newsletters or email news alerts. Other optional information that you enter when subscribing – such as your first and last names or city are simply so that we can deliver more personalized email newsletters. We DO NOT sell, rent or market your information to any other parties. We retain your information only as long as necessary to provide your service. When we send emails, it collects some data about which users open the emails and which links are clicked. We use this information to optimize our email newsletters and, as aggregate information, to explain what percentage of our users open and interact with our newsletters.
Personal Data
We only collect personally identifiable information such as your name and email address when you sign up for a newsletter, donate to our organization, or otherwise submit it to us voluntarily. We do not share your personal data with any third parties other than some common service providers, whose products use your information to help us improve our site, deliver newsletters, or allow us to offer donation opportunities.
inewsource limits access to all user data for the purposes of newsletter, fundraising, and customer service only. User data is not sold to or otherwise shared with anyone not working with or for the inewsource.
You may unsubscribe or opt-out of our email and mail communications at any time by hitting the “unsubscribe” button in any email you receive from inewsource, or by emailing us at contact@inewsource.org or calling us at 619-594-5100.
Donor Information
The identities of all donors will be listed on our website. inewsource does not share, trade, sell, or otherwise release donors’ personal information to any third parties.
Refunds
If you encounter errors when donating on the website, please contact us at members@inewsource.org. For example, if you submit a donation for an incorrect amount or make a duplicate transaction please email us immediately so we can reverse the charges.
Cancellation of Recurring Donations
You can cancel your monthly recurring donations free of charge by notifying us at members@inewsource.org.
Links to Other Websites
Our site may contain links to documents, resources or other websites that we think may be of interest to you. We have no control over these other sites or their content. You should be aware when you leave our site for another, and remember that other sites are governed by their own user agreements and privacy policies, which should be available to you to read.
Disclaimers and Limitation of Liability
Although we take reasonable steps to prevent the introduction of viruses, worms, “Trojan Horses” or other destructive materials to our site, we do not guarantee or warrant that our site or materials that may be downloaded from our site are free from such destructive features. We are not liable for any damages or harm attributable to such features. We are not liable for any claim, loss or injust based on errors, omissions, interruptions or other inaccuracies on our site, nor for any claim, loss or injust that results from your use of this site or your breach of any provision of this User Agreement.
Contact Us
If there are any questions regarding this privacy policy, please contact us at contact@inewsource.org or call us at 619-594-5100.